These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 15662593

  • 21. Peroxisome proliferator-activated receptor (PPAR) delta genetic polymorphism and its association with insulin resistance index and fasting plasma glucose concentrations in Chinese subjects.
    Hu C, Jia W, Fang Q, Zhang R, Wang C, Lu J, Xiang K.
    Diabet Med; 2006 Dec; 23(12):1307-12. PubMed ID: 17116180
    [Abstract] [Full Text] [Related]

  • 22. Alcohol consumption and higher incidence of impaired fasting glucose or type 2 diabetes in obese Korean men.
    Roh WG, Shin HC, Choi JH, Lee YJ, Kim K.
    Alcohol; 2009 Dec; 43(8):643-8. PubMed ID: 20004342
    [Abstract] [Full Text] [Related]

  • 23. Validity of plasma fibrinogen, D-dimer, and the von Willebrand factor as markers of cardiovascular morbidity in patients on chronic hemodialysis.
    Kirmizis D, Tsiandoulas A, Pangalou M, Koutoupa E, Rozi P, Protopappa M, Barboutis K.
    Med Sci Monit; 2006 Feb; 12(2):CR55-62. PubMed ID: 16449948
    [Abstract] [Full Text] [Related]

  • 24. D-dimer levels in type 1 and type 2 diabetic children and adolescents; Relation to microvascular complications and dyslipidemia "own data and review".
    El Asrar MA, Adly AA, El Hadidy ES, Abdelwahab MA.
    Pediatr Endocrinol Rev; 2012 Mar; 9(3):657-68. PubMed ID: 22523834
    [Abstract] [Full Text] [Related]

  • 25. Circulating obestatin levels in normal subjects and in patients with impaired glucose regulation and type 2 diabetes mellitus.
    Qi X, Li L, Yang G, Liu J, Li K, Tang Y, Liou H, Boden G.
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):593-7. PubMed ID: 17371480
    [Abstract] [Full Text] [Related]

  • 26. Five-year predictive factors of type 2 diabetes in men with impaired fasting glucose.
    Lecomte P, Vol S, Cacès E, Born C, Chabrolle C, Lasfargues G, Halimi JM, Tichet J.
    Diabetes Metab; 2007 Apr; 33(2):140-7. PubMed ID: 17320447
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Caribbean female patients with type 2 diabetes mellitus have lower serum levels of adiponectin than nondiabetic subjects.
    Ezenwaka CE, Kalloo R.
    Neth J Med; 2005 Feb; 63(2):64-9. PubMed ID: 15766010
    [Abstract] [Full Text] [Related]

  • 29. Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose.
    Abdul-Ghani MA, Williams K, DeFronzo R, Stern M.
    Diabetes Care; 2006 Jul; 29(7):1613-8. PubMed ID: 16801587
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Increased alanine aminotransferase level and future risk of type 2 diabetes and impaired fasting glucose among the employees in a university hospital in Thailand.
    Jiamjarasrangsi W, Sangwatanaroj S, Lohsoonthorn V, Lertmaharit S.
    Diabetes Metab; 2008 Jun; 34(3):283-9. PubMed ID: 18486512
    [Abstract] [Full Text] [Related]

  • 32. Relationship of glucose concentrations with PAI-1 and t-PA in subjects with normal glucose tolerance.
    Heldgaard PE, Sidelmann JJ, Hindsberger C, Olivarius Nde F, Henriksen JE, Gram J.
    Diabet Med; 2006 Aug; 23(8):887-93. PubMed ID: 16911627
    [Abstract] [Full Text] [Related]

  • 33. Differences in cardiovascular risk profile based on relationship between post-load plasma glucose and fasting plasma levels.
    Succurro E, Marini MA, Grembiale A, Lugarà M, Andreozzi F, Sciacqua A, Hribal ML, Lauro R, Perticone F, Sesti G.
    Diabetes Metab Res Rev; 2009 May; 25(4):351-6. PubMed ID: 19319930
    [Abstract] [Full Text] [Related]

  • 34. Plasma D-dimer concentration in patients with systemic sclerosis.
    Marie I, Borg JY, Hellot MF, Levesque H.
    Br J Dermatol; 2008 Feb; 158(2):392-5. PubMed ID: 18028493
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The influence of chromium chloride-containing milk to glycemic control of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial.
    Pei D, Hsieh CH, Hung YJ, Li JC, Lee CH, Kuo SW.
    Metabolism; 2006 Jul; 55(7):923-7. PubMed ID: 16784965
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [Abstract] [Full Text] [Related]

  • 39. Metabolic and cardiovascular risk factors in subjects with impaired fasting glucose: the 100 versus 110 mg/dL threshold.
    Andreozzi F, Succurro E, Mancuso MR, Perticone M, Sciacqua A, Perticone F, Sesti G.
    Diabetes Metab Res Rev; 2007 Oct; 23(7):547-50. PubMed ID: 17311284
    [Abstract] [Full Text] [Related]

  • 40. Frequency of abnormal carbohydrate metabolism and diabetes in a population-based screening of adolescents.
    Dolan LM, Bean J, D'Alessio D, Cohen RM, Morrison JA, Goodman E, Daniels SR.
    J Pediatr; 2005 Jun; 146(6):751-8. PubMed ID: 15973311
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.